Markets › India › NSE › PAR

Par Drugs and Chemicals Ltd

NSE:PARHealthcare

₹105.72−3.48%At closeAt close · Mon 19 Oct · ≈ AED 4.08 · Market cap $13.69M

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	TTM	YoY
Revenue	0.6	0.7	1.0	1.0	1.0	1.0	1.1	+5.0%
Cost of revenue	0.4	0.5	0.7	0.3	0.4	0.5	0.6	+5.1%
Gross profit	0.2	0.2	0.3	0.6	0.6	0.5	0.5	+4.9%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Selling, general & administrative	0.0	0.0	0.1	0.1	0.1	0.4	—	—
Selling & marketing	0.0	0.0	0.0	0.1	0.0	0.0	—	—
Operating expenses	0.1	0.0	0.1	0.1	0.1	0.4	0.4	−0.7%
Operating income	0.1	0.1	0.1	0.6	0.2	0.1	0.2	+20.5%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	—
Other income / expense	0.0	0.0	0.0	(0.4)	0.0	0.0	—	—
Pre-tax income	0.1	0.1	0.2	0.2	0.2	0.2	0.2	+10.7%
Income tax	0.0	0.0	0.0	0.1	0.0	0.0	0.0	+11.2%
Net income	0.1	0.1	0.1	0.1	0.1	0.1	0.1	+10.6%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	(0.0)	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	9.45	7.49	9.21	11.78	10.86	10.65	11.78	+10.6%
EPS, diluted (per share)	9.45	7.49	9.21	11.78	10.86	10.65	11.78	+10.6%
EBITDA	0.2	0.2	0.2	0.2	0.2	0.2	0.2	−5.6%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Weighted average shares (shares)	12,285,590	12,304,636	12,304,636	12,309,847	12,300,000	12,309,000	—	—
Weighted average diluted shares (shares)	12,288,063	12,304,636	12,304,636	12,304,636	12,300,000	12,309,000	—	—
Gross margin	37.5%	32.6%	30.2%	63.8%	62.2%	48.7%	48.6%	−0.0 pts
Operating margin	22.0%	17.0%	15.3%	57.7%	15.9%	13.0%	14.9%	+1.9 pts
Net margin	19.4%	12.3%	11.9%	15.2%	13.2%	12.6%	13.3%	+0.7 pts

INR billionsUpdated Tue 30 Jun ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.